Total Returns (Price + Dividend) 
CSPC Innovation Pharmaceutical Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News

CSPC Innovation Pharmaceutical Hits Day Low Amid Price Pressure at CNY 35.62
CSPC Innovation Pharmaceutical Co., Ltd. faced notable volatility on October 24, 2025, with a significant stock decline. Over the past week and month, the stock has dropped considerably, while the company has reported negative results for six consecutive quarters, raising concerns about its long-term growth metrics and profitability.
Read More
CSPC Innovation Stock Hits Day Low of CNY 40.55 Amid Price Pressure
CSPC Innovation Pharmaceutical Co., Ltd. saw a notable stock decline, contrasting with the broader market's gains. The company has faced ongoing financial challenges, including significant drops in net sales and profits over recent quarters, raising concerns about its stability despite a strong year-to-date performance.
Read More
CSPC Innovation Stock Hits Day Low Amid Price Pressure at CNY 41.87
CSPC Innovation Pharmaceutical Co., Ltd. saw a significant stock decline today, contrasting with the minor decrease in the China Shanghai Composite. The company has faced a notable downturn over the past week and month, with ongoing financial challenges reflected in negative sales and profit metrics.
Read More Announcements 
Corporate Actions 
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot
Shareholding Compare (%holding) 
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ
QoQ Growth in quarter ended Jun 2025 is 22.70% vs -5.87% in Mar 2025
QoQ Growth in quarter ended Jun 2025 is 68.82% vs 44.53% in Mar 2025
Annual Results Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is -22.12% vs -4.01% in Dec 2023
YoY Growth in year ended Dec 2024 is -341.21% vs -82.70% in Dec 2023






